HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder/Allergan Marriage Delivers Clinique Medical For Cosmetic Procedures

This article was originally published in The Rose Sheet

Executive Summary

The Estee Lauder Companies has joined with pharmaceutical firm Allergan to launch Clinique Medical, a line of skin-care products designed to prepare skin for non-surgical cosmetic procedures and assist in the healing process, the firm says Oct. 15

You may also be interested in...



Dr. Jacknin Profiles "Cutting-Edge" Natural Cosmeceutical Ingredients

Dermatologist Jeanette Jacknin's rundown of "new natural cutting-edge ingredients for cosmeceuticals" suggests that South America is still the place to go for high-performance skin-care ingredients

Dr. Jacknin Profiles "Cutting-Edge" Natural Cosmeceutical Ingredients

Dermatologist Jeanette Jacknin's rundown of "new natural cutting-edge ingredients for cosmeceuticals" suggests that South America is still the place to go for high-performance skin-care ingredients

RegeneRx Seeks Cosmeceutical Partners While Developing Drugs

Cash-strapped Maryland biotech firm RegeneRx is in talks with global cosmetics firms to develop products from its drug candidate molecule T?4 and hopes to see revenue from cosmeceuticals by 2010

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel